About Health Technology Access

Health Technology Access is a market access company specialising in health economic evaluation.  The General Manager of Health Technology Access is Dr Steven Fearn.  On most occasions, you will be dealing directly with Steven.  Steven has served on NICE’s Topic Selection Panel for Vascular & Metabolic Conditions (Coronary Artery Disease, Peripheral Arterial Disease, diabetes & renal disease), NICE’s Medical Technology Advisory Committee & NICE’s Task & Finish Group for handling uncertainty as part of the Methods Review.  Steven was also a member of the Health Technology Wales Industry Reference Group and was Vice Chair of the Association of British Healthtech Industry’s Market Access Policy Group.

Steven has experience of drug-eluting coronary stents (led a company through a NICE Technology Appraisal), PCI, diagnostic coronary catheterisation, interventional radiology, vascular surgery, cardiac surgery, cardiac resynchronisation therapy, implantable defibrillators, pacemakers, patent foramen ovale closure, left atrial appendage occlusion, mitral valve repair, mitral valve replacement, aortic valve replacement (called TAVI in the UK and TAVR in the USA), cardiac electrophysiology, heart failure and neuromodulation.

Steven has over 36 years of experience in the medical device industry, including over 26 years of market access experience.  Steven also has experience in the operation of the NHS, commissioning systems, NHS-related institutions (eg NICE), political engagement, clinical coding, payment system, writing business cases, the conduct of clinical trials in the UK and the use of NHS administrative data to understand activity.  Steven is named as an author on several publications that relate to near infrared spectroscopy (a medical technology), bare metal coronary stents, percutaneous direct myocardial laser revascularisation (a medical technology), peripheral arterial disease, drug-eluting coronary stents and cardiac resynchronisation therapy.

Health Technology Access can perform probabilistic analysis (a way of handling uncertainty), which is preferred by assessors of economic value.  Cardiovascular devices are a particular area of expertise.